Alexander Greenshields‐Watson
- Immunology top 10%
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 5
-
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- vaccines and immunoinformatics approaches 5
- Glycosylation and Glycoproteins Research 2
Alexander Greenshields‐Watson
17 papers receiving 406 citations
Peers
Comparison fields: 5 of 54
- Immunology 240
- Oncology 141
- Radiology, Nuclear Medicine and Imaging 74
- Molecular Biology 207
- Infectious Diseases 55
Countries citing papers authored by Alexander Greenshields‐Watson
This map shows the geographic impact of Alexander Greenshields‐Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Greenshields‐Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Greenshields‐Watson more than expected).
Fields of papers citing papers by Alexander Greenshields‐Watson
This network shows the impact of papers produced by Alexander Greenshields‐Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Greenshields‐Watson. The network helps show where Alexander Greenshields‐Watson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexander Greenshields‐Watson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 22 | |
| 10 | 2020 | 23 | |
| 11 | 2019 | 47 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 229 | |
| 14 | 2018 | 11 | |
| 15 | 2017 | 5 | |
| 16 | 2017 | 3 | |
| 17 | 2016 | 20 |
About Alexander Greenshields‐Watson
Alexander Greenshields‐Watson is a scholar working on Immunology, Ophthalmology and Oncology, having authored 17 papers that have together received 410 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), vaccines and immunoinformatics approaches (5 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (240 citations), Oncology (141 citations) and Radiology, Nuclear Medicine and Imaging (74 citations). Alexander Greenshields‐Watson has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include David K. Cole, Andrew Godkin, Andrew K. Sewell, Garry Dolton, Cristina Rius, Jerome Samir, Can Keşmir, Meriem Attaf, Dmitry Bagaev and Dmitriy M. Chudakov. Their work appears in journals such as Annals of Oncology, Cell Reports, Journal of Visualized Experiments, Nucleic Acids Research and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.